P

Pfizer

Makes cancer drugs, vaccines and other medicines

Vaccines Operational Excellence Director - Continuous Improvement and Project Management

Full-TimeUpdated on 10/20/2026Deadline 10/26/26
$176.6k - $294.3k/yr+ 20% bonus target + Share-based long-term incentive
Expert
Bachelor's, Master's, PharmD, PhD
Collegeville, PA, USA+3 moreMore locations: Pearl River, NY, USA | Marlow, UK | New York, NY, USA
In PersonRelocation assistance may be available based on business needs and/or eligibility. Travel up to 10%, including potential international travel.
Project & Program ManagementProgram Management
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree and 10+ years of experience in the pharmaceutical industry or related fields are required; alternatively, an advanced degree such as a master's with 8+ years, or a PharmD/PhD with 6+ years, is required.
  • Prior experience working in a Medical Affairs organization is essential; experience in other medical or clinical functions is desirable.
  • Prior experience in project management or business operations is required.
  • Understanding and adherence to project management methodologies are required.
  • Demonstrated results creating and managing complex projects, including budgetary management and fiscal awareness, are required.
  • Ability to collaborate across Medical (customer-facing and headquarters), Medical Information, Corporate Communications, Digital, and Commercial functions is required.
  • Ability to manage resources, programs, and multiple projects is required.
  • Strong communication and relationship-building ability, including listening to, understanding, and integrating country and local needs into global co-created medical strategies and plans, is required.
  • Ability to lead effectively in a matrix and communicate and work effectively with all levels of management is required.
  • Ability to facilitate open discussion and debate among stakeholders and build relationships through partnering, anticipating needs, and fulfilling expectations is required.
  • Independence, proactivity, self-motivation, strong organizational skills, and the ability to manage priorities, handle multiple tasks, and meet frequent tight deadlines are required.
  • Attention to detail and follow-up skills are required.
  • Knowledge of Pfizer systems, including POD, Ariba BOD, and EngagePlus, is required.
  • High proficiency in Microsoft Excel, Word, PowerPoint, and Teams is required.
  • Ability to work in a fast-paced environment is required.
  • Strong decision-making skills are required.
  • An entrepreneurial mindset is required.
  • Strong communication skills and the ability to work effectively with senior management are required.
  • Resourcefulness and the ability to keep pace with a changing environment are required.
  • Strong strategic thinking and strategic development skills are required.
  • Excellent business judgment is required.
  • Full knowledge and understanding of all relevant applicable standard operating procedures is required.
  • A proven record of implementing strategically important projects on time and within budget is required.
  • Ability to operate effectively in a heavily matrixed organization and manage projects with team members in multiple locations is required.
  • Ability to influence without authority is required.
  • Strong communication and interpersonal skills, including spoken and written English fluency and the ability to influence others, are required.
  • Flexibility and the ability to adapt to change, external conditions, project scope, and direction are required.
  • Permanent work authorization in the United States and authorization to be employed in the U.S. by any employer are required.
Responsibilities
  • Support assigned Asset Medical Affairs Leads in aligning and coordinating goals, priorities, and efforts across Medical Affairs categories and asset teams and with cross-functional partners.
  • Contribute as a thought partner to assigned Asset Medical Affairs Leads and teams to develop and define future-looking vision, mission, and strategic initiatives.
  • Establish and maintain structures for co-creation and prioritized co-execution of global and/or U.S. medical plans.
  • Support implementation of Medical Affairs organizational and team-specific change management plans in collaboration with Change Management team members.
  • Identify, raise, share, and implement best practices; ensure consistency in overarching processes and systems where needed; and develop partnerships with colleagues in other functions to maintain alignment and efficiency.
  • Develop and maintain business relationships with Finance, Contracts & Outsourcing, Compliance, and Operational Excellence colleagues to advance Medical Affairs projects.
  • Drive creation and implementation of medical processes and appropriate standard operating procedures with stakeholders to support Medical Affairs strategy and execution of data generation and communication activities.
  • Coordinate with Operational Excellence team members across categories to standardize approaches, processes, and standard operating procedures.
  • Support asset-specific governance committees to advance effective decision-making.
  • Support assigned Medical Affairs activities and initiatives, including advisory boards and medical congresses, by developing and monitoring project and program plans and tracking milestones.
  • Lead stakeholder and process coordination for effective launch planning in collaboration with Launch Excellence team members.
  • Drive agendas and facilitate Medical Team meetings, ensuring minutes are recorded and filed.
  • Provide presentation development support for internal meetings.
  • Develop and lead tracking of performance and activity metrics, as appropriate, and share and coordinate them with the Medical Impact and Outcomes team.
  • Collaborate and align with internal stakeholders and other Operational Excellence colleagues to ensure consistency and alignment.
  • Manage all financial management, forecasting, and accruals for the assigned Asset or Field Medical area.
  • Provide budget and resource information to Medical Leads to support portfolio management and align priorities with resource allocation.
  • Develop integrated Medical project and program budget plans for the Asset and/or Field Medical Group.
  • Collaborate with Medical, Finance, and Financial Systems teams to ensure accurate forecasting and budget management.
  • Maintain financial information and data integrity in source systems and platforms, partnering with the Portfolio on Demand team and other stakeholders to support timely contracting and project and financial tracking.
  • Develop and maintain project forecasts to provide management with accurate year-to-date budget spend.
  • Provide financial guidance and serve as a resource for questions.
  • Manage the process and development of the Asset and/or Field Medical Strategic and Operating Plan.
Desired Qualifications
  • An advanced degree, such as a master's, is highly preferred.
  • Experience in other medical or clinical functions is desirable.
  • Experience leading innovation that serves future healthcare needs is desired.
  • Pfizer values of Courage, Excellence, Equity, and Joy are emphasized as qualities to model.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.

Yahoo Finance
Oct 12th, 2026
UPS, Pfizer, Kraft Heinz and Ford dividends at risk as payouts outstrip earnings

Four blue chip companies, UPS, Pfizer, Kraft Heinz, and Ford, may struggle to sustain their dividends, according to an analysis of their earnings, cash flow, and debt. UPS yields 7.02% and pays out about 121% of its GAAP earnings. Pfizer yields 6.10%, with a GAAP payout ratio of about 226%; its 2025 free cash flow of $9.076 billion fell short of $9.771 billion in dividends. Kraft Heinz yields 6.82%, but its trailing GAAP earnings per share are −$2.88 after $7.4 billion in impairments. Ford yields 4.98% after an $8.162 billion loss in 2025, and its debt-to-equity ratio is 4.66. All four companies say their payouts are safe, and each points to adjusted earnings guidance that covers the dividend.